| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 247 | 2023 |
| The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus O Ünlü, S Zuily, D Erkan European journal of rheumatology 3 (2), 75, 2016 | 210 | 2016 |
| Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis L Arnaud, A Mathian, A Ruffatti, D Erkan, M Tektonidou, R Cervera, ... Autoimmunity Reviews 13 (3), 281-291, 2014 | 203 | 2014 |
| Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies S Zuily, V Regnault, C Selton-Suty, V Eschwège, JF Bruntz, E Bode-Dotto, ... Circulation 124 (2), 215-224, 2011 | 189 | 2011 |
| Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis V Dufrost, J Risse, T Reshetnyak, M Satybaldyeva, Y Du, XX Yan, S Salta, ... Autoimmunity reviews 17 (10), 1011-1021, 2018 | 177 | 2018 |
| Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry CP Denton, T Krieg, L Guillevin, B Schwierin, D Rosenberg, M Silkey, ... Annals of the rheumatic diseases 71 (5), 718-721, 2012 | 119 | 2012 |
| Direct oral anticoagulants use in antiphospholipid syndrome: are these drugs an effective and safe alternative to warfarin? A systematic review of the literature V Dufrost, J Risse, S Zuily, D Wahl Current rheumatology reports 18, 1-8, 2016 | 113 | 2016 |
| Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society … S Zuily, H Cohen, D Isenberg, SC Woller, M Crowther, V Dufrost, D Wahl, ... Journal of thrombosis and haemostasis 18 (9), 2126-2137, 2020 | 111 | 2020 |
| Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: a pilot study C Meune, S Zuily, K Wahbi, YE Claessens, S Weber, ... Archives of cardiovascular diseases 104 (1), 4-10, 2011 | 105 | 2011 |
| Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. E Hunsche, T Krieg, B Schwierin, D Rosenberg, B Raffier, M Hirschi, ... Clinical and experimental rheumatology 31 (2 Suppl 76), 71-80, 2013 | 101 | 2013 |
| Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration T Tritschler, ME Mathieu, L Skeith, M Rodger, S Middeldorp, T Brighton, ... Journal of thrombosis and haemostasis 18 (11), 2958-2967, 2020 | 95 | 2020 |
| International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease PA Olivera, S Zuily, PG Kotze, V Regnault, S Al Awadhi, P Bossuyt, ... Nature Reviews Gastroenterology & Hepatology 18 (12), 857-873, 2021 | 93 | 2021 |
| Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study S Zuily, B De Laat, S Mohamed, H Kelchtermans, Z Shums, R Albesa, ... Rheumatology 54 (11), 2071-2075, 2015 | 90 | 2015 |
| Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction C Chenevier-Gobeaux, C Meune, Y Freund, K Wahbi, YE Claessens, ... The American journal of cardiology 111 (12), 1701-1707, 2013 | 88 | 2013 |
| Valvular heart disease in antiphospholipid syndrome S Zuily, O Huttin, S Mohamed, PY Marie, C Selton-Suty, D Wahl Current rheumatology reports 15, 1-7, 2013 | 87 | 2013 |
| Ischemic digital ulcers affect hand disability and pain in systemic sclerosis L Mouthon, PH Carpentier, C Lok, P Clerson, V Gressin, E Hachulla, ... The Journal of rheumatology 41 (7), 1317-1323, 2014 | 84 | 2014 |
| Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria M Barbhaiya, S Zuily, Y Ahmadzadeh, MC Amigo, T Avcin, ... Arthritis care & research 73 (10), 1490-1501, 2021 | 80 | 2021 |
| How to limit radial artery spasm during percutaneous coronary interventions: the spasmolytic agents to avoid spasm during transradial percutaneous coronary interventions … J Rosencher, A Chaïb, F Barbou, MA Arnould, A Huber, E Salengro, ... Catheterization and Cardiovascular Interventions 84 (5), 766-771, 2014 | 70 | 2014 |
| Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease D Erkan, O Unlu, S Sciascia, HM Belmont, DW Branch, MJ Cuadrado, ... Lupus 27 (3), 399-406, 2018 | 65 | 2018 |
| ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease H Gordon, J Burisch, P Ellul, K Karmiris, K Katsanos, M Allocca, G Bamias, ... Journal of Crohn's and Colitis 18 (1), 1-37, 2024 | 61 | 2024 |
